Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated with Virologic Failure: Results from the Multinational PEARLS (ACTG A5175) Clinical Trial

by Kantor R., Smeaton L., Vardhanabhuti S., Hudelson S., Wallis C., Tripathy S., Morgado M., Saravanan S., Balakrishnan P., Reitsma M., Hart S., Mellors J., Halvas E., Grinsztejn B., Hosseinipour M., Kumwenda J., La Rosa A., Lalloo U., Lama J., Rassool M., Santos B., Supparatpinyo K., Hakim J., Flanigan T., Kumarasamy N., Campbell T., Eshleman S.
Published 2015

International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271

by Robertson K., Jiang H., Evans S., Marra C., Berzins B., Hakim J., Sacktor N., Silva M., Campbell T., Nair A., Schouten J., With the 5271 study team, Kumwenda J., Supparatpinyo K., Tripathy S., Kumarasamy N., la Rosa A., Montano S., Mwafongo A., Firnhaber C., Sanne I., Naini L., Amod F., Walawander A.
Published 2017

Analysis of genetic linkage of HIV from couples enrolled in the HIV prevention trials network 052 trial

by Eshleman S., Hudelson S., Redd A., Wang L., Debes R., Chen Y., Martens C., Ricklefs S., Selig E., Porcella S., Munshaw S., Ray S., Piwowar-Manning E., McCauley M., Hosseinipour M., Kumwenda J., Hakim J., Chariyalertsak S., De Bruyn G., Grinsztejn B., Kumarasamy N., Makhema J., Mayer K., Pilotto J., Santos B., Quinn T., Cohen M., Hughes J.
Published 2017

Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: Aids clinical trials group study A5199, the inte...

by Robertson K., Jiang H., Kumwenda J., Supparatpinyo K., Evans S., Campbell T., Price R., Tripathy S., Kumarasamy N., La Rosa A., Santos B., Silva M., Montano S., Kanyama C., Faesen S., Murphy R., Hall C., Marra C., Marcus C., Berzins B., Allen R., Housseinipour M., Amod F., Sanne I., Hakim J., Walawander A., Nair A.
Published 2017

A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings

by Robertson K., Kumwenda J., Supparatpinyo K., Jiang J., Evans S., Campbell T., Price R., Murphy R., Hall C., Marra C., Marcus C., Berzins B., Masih R., Santos B., Silva M., Kumarasamy N., Walawander A., Nair A., Tripathy S., Kanyama C., Hosseinipour M., Montano S., La Rosa A., Amod F., Sanne I., Firnhaber C., Hakim J., Brouwers P.
Published 2017

Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results from the HIV Prevention Trials Network 052 Trial

by Fogel J., Hudelson S., Ou S., Hart S., Wallis C., Morgado M., Saravanan S., Tripathy S., Hovind L., Piwowar-Manning E., Sabin D., McCauley M., Gamble T., Zhang X., Eron J., Gallant J., Kumwenda J., Makhema J., Kumarasamy N., Chariyalertsak S., Hakim J., Badal-Faesen S., Akelo V., Hosseinipour M., Santos B., Godbole S., Pilotto J., Grinsztejn B., Panchia R., Mayer K., Chen Y., Cohen M., Eshleman S.
Published 2017

Prevention of HIV-1 infection with early antiretroviral therapy

by Cohen M., Chen Y., McCauley M., Gamble T., Hosseinipour M., Kumarasamy N., Hakim J., Kumwenda J., Grinsztejn B., Pilotto J., Godbole S., Mehendale S., Chariyalertsak S., Santos B., Mayer K., Hoffman I., Eshleman S., Piwowar-Manning E., Wang L., Makhema J., Mills L., De Bruyn G., Sanne I., Eron J., Gallant J., Havlir D., Swindells S., Ribaudo H., Elharrar V., Burns D., Taha T., Nielsen-Saines K., Celentano D., Essex M., Fleming T.
Published 2017

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phas...

by Tang M.W., Rhee S.-Y., Bertagnolio S., Ford N., Holmes S., Sigaloff K.C., Hamers R.L., De Wit T.F.R., Fleury H.J., Kanki P.J., Ruxrungtham K., Hawkins C.A., Wallis C.L., Stevens W., Van Zyl G.U., Manosuthi W., Hosseinipour M.C., Ngo-Giang-Huong N., Belec L., Peeters M., Aghokeng A., Bunupuradah T., Burda S., Cane P., Cappelli G., Charpentier C., Dagnra A.Y., Deshpande A.K., El-Katib Z., Eshleman S.H., Fokam J., Gody J.-C., Katzenstein D., Koyalta D.D., Kumwenda J.J., Lallemant M., Lynen L., Marconi V.C., Margot N.A., Moussa S., Ndung'U T., Nyambi P.N., Orrell C., Schapiro J.M., Schuurman R., Sirivichayakul S., Smith D., Zolfo M., Jordan M.R., Shafer R.W.
Published 2014

Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings

by Campbell T., Smeaton L., Kumarasamy N., Flanigan T., Klingman K., Firnhaber C., Grinsztejn B., Hosseinipour M., Kumwenda J., Lalloo U., Riviere C., Sanchez J., Melo M., Supparatpinyo K., Tripathy S., Martinez A., Nair A., Walawander A., Moran L., Chen Y., Snowden W., Rooney J., Uy J., Schooley R., de Gruttola V., Hakim J., Swann E., Barnett R., Brizz B., Delph Y., Gettinger N., Mitsuyasu R., Eshleman S., Safren S., Fiscus S., Andrade A., Haas D., Amod F., Berthaud V., Bollinger R., Bryson Y., Celentano D., Chilongozi D., Cohen M., Collier A., Currier J., Cu-Uvin S., Eron J., Flexner C., Gallant J., Gulick R., Hammer S., Hoffman I., Kazembe P., Kumwenda N., Lama J., Lawrence J., Maponga C., Martinson F., Mayer K., Nielsen K., Pendame R., Ramratnam B., Sanne I., Severe P., Sirisanthana T., Solomon S., Tabet S., Taha T., van der Horst C., Wanke C., Gormley J., Marcus C., Putnam B., Ntshele S., Loeliger E., Pappa K., Webb N., Shugarts D., Winters M., Descallar R., Steele J., Wulfsohn M., Said F., Chen Y., Martin J., Bischofberger N., Cheng A., Jaffe H., Sharma J., Poongulali S., Cardoso S., Faria D., Berendes S., Burke K., Mngqibisa R., Kanyama C., Kayoyo V., Samaneka W., Chisada A.
Published 2017